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Abstract
Gold nanohexapods represent a novel class of optically tunable nanostructures consisting of an
octahedral core and six arms grown on its vertices. By controlling the length of the arms, their
localized surface plasmon resonance peaks could be tuned from the visible to the near-infrared
region for deep penetration of light into soft tissues. Herein we compare the in vitro and in vivo
capabilities of Au nanohexapods as photothermal transducers for theranostic applications by
benchmarking against those of Au nanorods and nanocages. While all these Au nanostructures
could absorb and convert near-infrared light into heat, Au nanohexapods exhibited the highest
cellular uptake and the lowest cytotoxicity in vitro for both the as-prepared and PEGylated
nanostructures. In vivo pharmacokinetic studies showed that the PEGylated Au nanohexapods had
significant blood circulation and tumor accumulation in a mouse breast cancer model. Following
photothermal treatment, substantial heat was produced in situ and the tumor metabolism was
greatly reduced for all these Au nanostructures, as determined with 18F-flourodeoxyglucose
positron emission tomography/computed tomography (18F-FDG PET/CT). Combined together, we
can conclude that Au nanohexapods are promising candidates for cancer theranostics in terms of
both photothermal destruction and contrast-enhanced diagnosis.
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Photothermal treatment, also known as photothermal ablation or optical hyperthermia, has
been actively explored as a minimally invasive approach to cancer therapy.1 It is a procedure
based on localized heating due to light absorption for selective destruction of abnormal cells.
In general, near-infrared (NIR, 700–1100 nm) light is preferred for such an application as it
can penetrate soft tissues deeply owing to the relatively low absorption/scattering by
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hemoglobin and water in this so-called transparent window.2,3 The key component of this
technique is a photothermal transducer that can absorb and convert NIR light into heat
through a non-radiative mechanism with high efficiency.4,5
Over the past decade, many different types of photothermal transducers have been reported,
including organic compounds or materials (e.g., indocyanine green (ICG)6 and
polyaniline7), metal nanostructures (e.g., Au nanostructures8 and Pd nanoplates9), and
carbon-based materials (e.g., carbon nanotubes10,11 and graphene oxide12,13). When
combined with NIR light, all of them were able to generate sufficient heat to raise the local
temperature and thus kill cancer cells. Of these photothermal transducers, Au nanostructures
have received great interest in recent years due to the fact that their localized surface
plasmon resonance (LSPR) peaks can be easily tuned to the NIR region by altering their
size, shape, structure, or a combination of these parameters.14 A wide variety of Au
nanostructures, including aggregates of colloidal particles,15 nanoshells,16 nanocages,17
nanorods,18 and nanocrosses19 have been demonstrated for photothermal cancer therapy
with NIR light. In general, the nanostructures should have the following features: i) large
absorption cross-sections in the NIR region; ii) easy functionalization with a “stealth”
coating together with targeting ligands to maximize their accumulation at the tumor site
following systemic administration; iii) appropriate size range (10–100 nm) to increase their
blood half-life and to reduce removal by the reticuloendothelial system (RES); and iv) good
biocompatibility especially in considering the possible long-term in vivo presence of the
nanostructures.20 Photothermal therapy has been demonstrated with certain types of Au
nanostructures in early clinical trials. As an example, pilot clinical studies with AuroShell®
(Au nanoshells with about 150 nm in diameter with a coating of polyethylene glycol 5000)
have been approved by FDA and given intravenously to patients for the treatment of head
and neck cancer, as well as primary and/or metastaic lung tumors.21,22 However, developing
Au nanostructures with all the aforementioned features remains to be achieved. For Au
nanoshells, they are typically more than 100 nm in diameter and tended to be removed by
the RES, primarily the liver and spleen.22 As for Au nanorods, the cetyltrimethylammonium
bromide (CTAB) used as a surfactant stabilizer for the synthesis could cause cytotoxicity
and thus needs to be replaced prior to any in vitro or in vivo application.23
Branched or star-shaped Au nanostructures consisting of a core and protruding arms have
recently received particular interest due to their unique morphology and optical
properties.24–27 Owing to the presence of sharp tips as well as their high surface-to-volume
ratios, branched Au nanostructures could be more effective in photothermal conversion and
drug loading relative to those with smooth surfaces.27 We recently reported a new class of
branched Au nanostructures -- Au nanohexapods, which consist of an octahedral core and
six arms grown on its six vertices.28 By controlling the length of the arms, the LSPR peaks
of the Au nanohexapods could be easily tuned from the visible to the NIR region.28
Therefore, Au nanohexapods are potential candidates as photothermal transducers for
various theranostic applications.
Herein we assessed the potential use of Au nanohexapods as photothermal transducers by
benchmarking against Au nanorods and nanocages. We found that Au nanohexapods
exhibited a comparable photothermal efficiency, higher cell uptake, and lower cell
cytotoxicity relative to Au nanorods and Au nanocages. More importantly, the in vivo
photothermal treatment studies with a MDA-MB-435 breast cancer model showed that Au
nanohexapods were also effective for photothermal destruction of tumor, following either
intravenous or intratumoral administration.
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RESULTS AND DISCUSSION
Preparation and Characterization of Au Nanostructures
The Au nanohexapods, consisting of an octahedral core and six arms grown on its six
vertices, were prepared by reducing HAuCl4 with DMF in an aqueous solution containing
Au octahedral seeds using a previously published protocol.28 By controlling the length of
the arms, the longitudinal LSPR peak was tuned to 805 nm (Figure 1A) to overlap with the
central wavelength of the diode laser (808 nm). In addition, a second peak was observed at
540 nm in the UV-vis spectrum, which could be attributed to the LSPR of the central
octahedral core.29 The surface of the as-prepared nanohexapods was covered by poly(vinyl
pyrrolidone) (PVP, Mw ≈ 55,000), a biocompatible polymer. Figure 1B shows a typical
TEM image of the nanohexapods, where the edge length of the octahedral cores was 25.3 ±
0.9 nm and the average dimensions of the arms were 16.3 ± 2.2 nm in length and 13.6 ± 1.8
nm in width, respectively. We measured the extinction coefficients of the Au nanohexapods
by using inductively coupled plasma mass spectrometer (ICP-MS) analysis to quantitatively
determine the concentration of Au nanohexapods in an aqueous suspension (see Supporting
Information for how to calculate the volume of a Au nanohexapod), and then combined it
with the extinction measured using a conventional UV-vis spectrometer to obtain a molar
extinction coefficient of 5.5×109 M−1 cm−1 at the longitudinal LSPR peak position (805
nm). We then used a method based on photoacoustic (PA) imaging (λ=800 nm) to measure
the molar absorption coefficient of the Au nanohexapods.30 In this case, the PA signal
intensities from suspensions of Au nanohexapods of various particle concentrations were
plotted as a function of concentration. As shown in Figure S1, the PA signal increased
linearly as the particle concentration was increased. The absorption coefficient of Au
nanohexapods was then obtained by benchmarking the PA signal against a linear calibration
curve obtained from a set of indocyanine green (ICG) solutions with different concentrations
by using the molar absorption coefficient reported for ICG at λ=800 nm (Figure S2).31 The
molar absorption coefficient of the Au nanohexapods was found to be 5.0×109 M−1 cm−1,
together with a ratio of absorption to extinction coefficients being 0.91. The large absorption
cross section of Au nanohexapods indicated that these highly branched structures were
effective in absorbing rather than scattering the incident light, suggesting their use as
photothermal transducers for theranostic applications.
The widely investigated photothermal transducers, Au nanocages and Au nanorods, were
chosen as benchmarks for a comparative study. Their LSPR peaks were also tuned to match
the central wavelength of the laser diode (808 nm). The preparation of Au nanorods was
performed using a seed-mediated growth method in the presence of the shape-directing
surfactant CTAB as described in literature.32, 33 The as-prepared Au nanorods had an LSPR
peak at 800 nm (Figure 1C), and an average length and width of 36.2 ± 2.3 and 9.1 ± 1.7
nm, respectively (Figure 1D). Their surfaces were covered by CTAB. As for Au nanocages,
they were prepared using a galvanic replacement reaction between Ag nanocubes and
HAuCl4 according to our published protocol.34 The as-prepared Au nanocages had an LSPR
peak at 802 nm (Figure 1E), an outer edge length of 47.4 ± 4.5 nm and an inner edge length
of 37.1 ± 2.7 nm, and a wall thickness of 5.2 nm (Figure 1F) and. Their surfaces were
covered by PVP.
We also used the discrete dipole approximation (DDA) method to calculate the extinction
cross section (σext) of Au nanohexapods at various orientations and found several plasmon
resonance peaks from 700 nm to 900 nm in addition to the resonance peak at 525 nm (Figure
S3). The peak positions were in reasonable agreement with the experimentally measured
values (Figure 1A). The appearance of only one relatively broad NIR peak in the measured
UV-vis spectrum was likely caused by the random orientations of the particles in the
solution and the polydispersity of the sample. Figure S3 also shows the scattering cross
Wang et al. Page 3
ACS Nano. Author manuscript; available in PMC 2014 March 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
section (σsca) computed for a Au nanohexapod, and its absorption cross section (σext, data
not shown) can be obtained from the equation: σext = σabs + σsca. The ratio of σabs to σext at
800 nm was calculated to be 0.96 for the Au nanohexapod, which was roughly on the same
order as what (0.91) was obtained experimentally from PA and UV-vis measurements. It is
worth noting that this ratio was larger than those calculated using DDA method for both Au
nanocages (0.82) with an outer edge length of 45.0 nm and Au nanorods (0.85) of 44.0 nm
in length and 19.8 nm in width, but comparable to that (0.94) of Au nanocages with an outer
edge length of 32.0 nm.30
Comparison of Photothermal Conversion In Vitro
We compared the photothermal conversion efficiencies of different types of Au
nanostructures by measuring the temperature rise for their aqueous suspensions upon laser
irradiation. Briefly, aqueous suspensions (100 μL) were placed in a single well of a 96-well
plate and the radiation was delivered using a diode laser centered at 808 nm from the top at a
density of 0.8 W/cm2. A NIR camera was placed about 25 cm above the solution, and
images were recorded at an interval of 15 s. The images were analyzed using the IR Flash
software to obtain the average temperature of the suspension. As shown in Figure 2A, the
suspension of Au nanohexapods (0.72 nM in particle concentration, with an extinction of 4.0
at 805 nm) showed a rapid increase in temperature during the first 3 min and eventually
reached a plateau with a total temperature increase of 36.5 °C. The rate of temperature rise
and the final temperature were proportional to the particle concentration; typically a slower
and smaller increase was observed for a lower concentration of Au nanohexapods.
For the purpose of comparison, the extinction intensities of different samples were adjusted
to 1.0 at 805 nm. As shown in Figure 2B, these three different types of Au nanostructures
had a more or less similar efficiency for photothermal conversion on the basis of the same
extinction intensity. However, given their large differences in structure and morphology,
their conversion efficiencies could be drastically different when normalized to the total mass
of Au atoms (or both Au and Ag atoms for the Au nanocage due to its alloyed
composition).35 As determined by ICP-MS, the concentrations of Au (or Au plus Ag for
nanocages) atoms for the nanostructures were 34.4 μg/mL for nanohexapods, 36.4 μg/mL
for nanorods, and 9.6 μg/mL for nanocages (together with an additional 3.3 μg/mL Ag
atoms). As such, the photothermal conversion efficiency per Au atom was highest for
nanocages, followed by nanohexapods, and then nanorods. It is worth noting that the
continuous-wave diode laser caused no change to the optical properties of all three Au
nanostructures, indicating that they were stable under the irradiation conditions. In the
absence of any Au nanostructures, the solution only increased in temperature by 0.5 °C after
5 min of constant irradiation under similar conditions (Figure 2B).
Comparison of Photothermal Stability
We further characterized the photothermal stability of the Au nanostructures under pulsed
laser irradiation. In a typical study, 100 μL of aqueous suspensions of Au nanostructures
were exposed to a pulsed laser (λ = 805 nm) at a power density ranging from 15 – 35 mW/
cm2 for 15 min. The UV-vis spectra were taken to assess the stability. As shown in Figure
S4, Au nanorods started to melt at 15 mW/cm2, whereas Au nanohexapods and nanocages
remained stable against laser irradiation under identical conditions without any observable
LSPR shift. Both Au nanohexapods and nanocages started to melt at 25 mW/cm2. Therefore,
the Au nanohexapods and nanocages are much more photothermally stable than the Au
nanorods.
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Cell Toxicity In Vitro
The toxicity of these Au nanostructures was assessed using an assay based on 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), which involves the use of
mitochondrial functional activity as an indicator. Figure 3A shows cell viabilities of MDA-
MB-435 breast cancer cells after incubation for 48 h with the as-prepared Au nanostructures
at different concentrations ranging from 1.56 to 200 μg/mL of Au atoms. For the CTAB-
coated Au nanorods, they displayed significant cytotoxicity at concentrations higher than 3
μg/mL, with a half maximal inhibitory concentration (IC50) of 10 μg/mL, indicating that
they were highly toxic due to the presence of CTAB. When the CTAB was replaced by PEG
(Mw ≈ 5,000), the observed cytotoxicity disappeared for samples with roughly the same
concentrations (Figure 3B), similar to what was observed by other groups.23 For PVP-coated
Au nanocages, they also showed observable cytotoxicity at high concentrations, with a 20%
loss of cell viability at 200 μg/mL (Figure 3A). The toxicity of Au nanocages was most
likely due to the presence of Ag atoms in the alloyed structure and subsequent release of
Ag+ ions from Au nanocages during incubation.35 After coating with PEG, the toxicity of
Au nanocages was also substantially reduced (Figure 3B). Importantly, no significant cell
toxicity was observed for either as-prepared or PEGylated Au nanohexapods at all
concentrations we tested. This could be attributed to their pure Au composition, as well as
the absence of a toxic surface capping ligand.
Cell Uptake In Vitro
Efficient cell entry is a prerequisite for Au nanostructures to function as photothermal
transducers or diagnostic agents. It is important to understand how the different geometries
of these Au nanostructures will impact their uptake by cells. The cell uptake was assessed
with MDA-MB-435 cells cultured on glass cover slips and placed either in the upright or
inverted configuration (with the cells facing the bottom of the cell culture plate).36 The
intracellular Au content was measured using ICP-MS following incubation for different
periods of time. It is known that different surface chemistries (i.e., capping ligands) will lead
to variation in nanostructure uptake.37–39 Therefore, we used PEGylated Au nanostructures
for the cell uptake study to eliminate such an effect. As shown in Figure 4A for the upright
configuration, the cell uptake of Au nanostructures was dependent on their geometries. The
uptake of PEGylated Au nanorods was lower than that of PEGylated Au nanohexapods,
while PEGylated Au nanocages had an intermediate uptake value. At 12 h after incubation,
the cell uptake of PEGylated Au nanohexapods by MDA-MB-435 cells was 3.2 and 1.2
times that of PEGylated Au nanorods and PEGylated Au nanocages, respectively. This
result indicates that the branched morphology of Au nanohexapods might have a higher
probability to enter the cell in comparison with the rod- or cube-like morphology. Similar
trends were also observed for the inverted configuration, where the sedimentation factor was
eliminated.36 The cell uptake was generally lower for cells in the inverted configuration than
in the upright configuration, especially for Au nanocages due to the relatively larger mass
for individual particles as well as the lower surface-to-volume ratio. Cellular uptake of
PEGylated Au nanohexapods was 3.0 and 1.5 times that of PEGylated Au nanorods and
PEGylated Au nanocages, respectively (Figure 4B).
Biodistributions
We next used an in vivo tumor model based on the MDA-MB-435 cell line to compare the
biodistributions of these PEGylated Au nanostructures in blood and tissues after intravenous
administration and their passive targeting efficiencies. PEG has been widely used to prevent
or minimize absorption of serum proteins from the blood and thus increase the blood
circulation time of nanostructures. The tumors were generated through subcutaneous
injection of MDA-MB-435 cells in the right flanks of athymic mice. After the tumors had
reached a proper size, the PEGylated Au nanostructures (100 μL, 4 nM in particle
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concentration) were injected through the tail vein and the Au content contained in the blood
and tissue samples were measured using ICP-MS at 6 h, 24 h, and 7 days post injection
(p.i.). As shown in Figure 5 for the PEGylated Au nanohexapods, approximately 6.5±1.3
%ID/g (expressed relative to injected dose per gram tissue or blood) and 7.2±1.2 %ID/g of
the injected particles were found in the tumor at 6 h and 24 h post-injection, respectively,
suggesting significant accumulation in tumors due to the enhanced permeability and
retention (EPR) effect in tumors with leaky vasculatures. The remaining PEGylated Au
nanohexapods were taken up predominantly by the liver and to a lesser extent by the spleen
related to the RES. Besides the liver and spleen, other organs with detectable Au levels were
heart and lung, and to a less extent kidney. The mice injected with the PEGylated Au
nanorods showed similar blood retention and accumulation (7.0±2.3 %ID/g at 6 h and
8.4±2.2 %ID/g at 24 h) in tumors. Both values were higher than the PEGylated Au
nanocages (2.4±1.2 %ID/g at 6 h and 2.6±0.8 %ID/g at 24 h). On the other hand, different
from PEGylated nanohexapods and nanocages, PEGylated Au nanorods showed a shift in
distribution towards the spleen. At 7 days p.i., (Figure 5C), the levels of Au in the liver and
spleen remained constant relative to those at 24 h. Interestingly, the concentrations of Au in
the kidney and the blood pool organs (heart, lung, and blood) slightly decreased over time,
indicating possible clearance of these Au nanostructures through the renal system. More
importantly, the tumor accumulations of all these Au nanostructures did not show significant
changes during the 7-day period of study, indicating stable residence in tumor. This feature
might be advantageous for repeated or long term photothermal treatment. These results
confirmed that the shape or morphology of nanostructures could influence their blood
circulation and biodistributions. It should be pointed out that the dimensions of the Au
nanostructures were different although the thicknesses of PEG coatings were roughly the
same. Furthermore, our preliminary in vivo toxicity evaluation via hematoxylin and eosin
staining did not show any observable adverse effect (Figure S5), indicating the in vivo
biocompatibility of all these Au nanostructures.
In Vivo Photothermal Capability of Au Nanohexapods
We first quantitatively analyzed the photothermal conversion of the Au nanohexapods using
a tumor model. In a typical study, either 40 μL of 1 nM Au nanohexapods (Figure S6, A1–
A4) or 40 μL of saline (Figure S6, B1–B4) was administered intratumorally to tumor-
bearing mice. Immediately after injection, the tumor regions were irradiated with a diode
laser (808 nm) at a power density of 1.0 W/cm2 for up to 5 min. The spot size was adjusted
to cover the entire tumor area. For the mouse injected with Au nanohexapods, thermal
images recorded at different time points indicate that the temperature of the tumor region
quickly increased and then reached a plateau upon laser irradiation. As shown in Figure
S6C, the temperature could easily reach a level (ΔT = 23.1 °C) capable of inducing
hyperthermia to kill cancer cells.17 In comparison, for the control mouse injected with
saline, the temperature recorded from the tumor region was still in the homeostatically
tolerable region, with ΔT = 4.2 °C. This result indicates that cell destruction will only result
when Au hexapods and laser irradiation are both involved.
Comparison of Photothermal Treatment In Vivo
We further compared the photothermal cancer treatment efficacies of these PEGylated Au
nanostructures in a bilateral MDA-MB-435 tumor model following intravenous
administration. Tumor-bearing mice were administered intravenously with either 200 μL of
the PEGylated Au nanostructures or 200 μL of saline, respectively (n = 3 per group). At 3
days post injection, the tumor on the left rear flank of each mouse was irradiated with a
diode laser (808 nm) at a power density of 1.2 W/cm2 for 10 min. For the mouse injected
with PEGylated Au nanostructures, the temperature of the tumor region quickly increased
and then reached a plateau upon laser irradiation, as compared with the mice injected with
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saline (Figure 6A). The images were analyzed using the IR Flash software to obtain the
average temperature of the suspension (Figure 6B). When compared with the PEGylated
nanorods (53.0±0.5 °C) and nanocages (48.7±3.5 °C), PEGylated nanohexapods showed the
highest (55.7±2.4 °C) photothermal conversion efficiency in vivo, owing to their highest
tumor uptake and photothermal conversion efficiency per Au atom.
We next evaluated the effects of photothermal treatment by observing the tumor metabolism
with 18F-FDG PET/CT. Following intravenous administration of the various types of
PEGylated Au nanostructures or saline, 18F-FDG PET/CT imaging was performed before
and 24 h after laser treatment. As shown in Figure 7A, the 18F-FDG uptake was significantly
reduced in the irradiated tumors in contrast to the contralateral non-irradiated tumors.
Quantitative analysis showed substantial decrease of tumor standardized uptake values
(SUVs) after the treatment for all the Au nanostructures while the non-irradiated tumors
showed constant metabolism during the study (Figure 7B). More importantly, the
irradiation/non-irradiation tumor SUV ratios demonstrated approximately 90% reduction of
tumor metabolism in mice treated with nanohexapods or nanorods and 80% decrease in mice
treated with nanocages, indicating almost complete destruction of tumor glycolic activity
after the photothermal treatment (Figure 7C). Further, four days after the treatment, no
visible tumors were observed in any of the treated mice.
The results indicate that all these PEGylated Au nanostructures could serve as effective
transducers for photothermal treatment of cancer. Although there was no significant
difference in treatment response from photothermal therapy as determined by 18F-FDG
uptake among the three Au nanostructures under the experimental conditions used in the
present work, nanohexapods did cause a higher rise in temperature than nanorods or
nanocages. Taken together, it is reasonable to expect that the combined high photothermal
efficiency, low cytotoxicity, and substantial accumulation in tumor make Au nanohexapods
a candidate photothermal transducer for further in vivo therapeutic evaluation. However,
there is still a long way to go before the nanohexapods and other types of Au nanostructures
can be translated into clinical practice. More efforts need to be devoted to further improve
the pharmacokinetics, targeting efficiency, and longitudinal toxicity.
CONCLUSIONS
In summary, we have evaluated the potential use of Au nanohexapods for applications in
photothermal cancer treatment. Our comparison studies with Au nanohexapods, nanorods,
and nanocages indicate that all these Au nanostructures could absorb and convert NIR light
into heat. Au nanohexapods exhibited the highest cellular uptake and the lowest cytotoxicity
in vitro for both the as-prepared and PEGylated samples. The PEGylated Au nanohexapods
also showed the significant blood circulation and tumor accumulation after intravenous
injection. More importantly, the nanohexapods could significantly decrease the tumor
metabolic activity following photothermal treatment after systemic administration.
Combined together, it can be concluded that Au nanohexapods are promising as both optical
therapeutic and diagnostic agents for a range of biomedical applications.
MATERIALS AND METHODS
Chemicals and Reagents
Poly(ethylene glycol) monomethyl ether thiol (mPEG-SH, Mw ≈ 5,000) was purchased
from Laysan Bio (Arab, AL). All other chemicals or reagents, including
cetyltrimethylammonium bromide (CTAB), dimethylformamide (DMF), chloroauric acid
(HAuCl4), indocyanine green (ICG), and (3-(4,5-dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTT), were obtained from Sigma-Aldrich (St. Louis, MO).
All chemicals were used as received.
Preparation and Characterization of Au Nanohexapods
The nanohexapods were prepared following our previously reported protocol with minor
modifications.28 In a typical synthesis, 0.2 mL of an aqueous suspension of the Au
octahedral seeds was mixed with 4.8 mL ultrapurified H2O (Millipore, Billerica, MA). At
the same time, 2 mL DMF and 1 mL ultrapurified H2O were mixed, heated to 120 °C for 10
min, and then cooled down to room temperature. 1 mL of this DMF/H2O mixture was then
added to the 5 mL suspension of Au octahedral seeds, followed by 10 μL of HAuCl4
solution in DMF (9.42 mM) under stirring. The color of the solution changed from pink-red
to blue. The HAuCl4 solution in DMF was added every 15 min (10 μL each time) until the
extinction peak of the reaction solution shifted to 805 nm. The product was collected by
centrifugation at 10,000 rpm for 12 min and washed with water twice. The product was
finally re-dispersed in water.
Synthesis of Au Nanocages
The nanocages were prepared using a galvanic replacement reaction between silver
nanocubes and HAuCl4 in an aqueous solution by following our previously published
protocol.34 The as-obtained nanocages was purified by centrifugation at 10,000 rpm for 10
min and washed twice with water. The product was finally re-dispersed in water.
Synthesis of Au Nanorods
The nanorods were synthesized using a seed-mediated method that involved the addition of
a suspension of Au spherical seeds to a growth solution in the presence of CTAB as a
capping agent.25 The as-obtained nanorods was purified by centrifugation at 8,000 rpm for
15 min and washed once with water. The product was finally re-dispersed in water.
Measurement of Absorption Cross Section by PA Imaging
We used a dark-field illumination PA imaging system for the measurement.40 A tunable
Ti:sapphire laser (tuned to 805 nm, LT-2211A, Lotis TII, Minsk, Belarus) pumped by a Q-
switched Nd:YAG laser (LS-2137, Lotis TII) was used for excitation at a pulse duration <
15-ns and a pulse repetition rate of 10 Hz. To protect the nanohexapods from melting/
deformation or the ICG molecules from photobleaching, Tygon tubes were embedded in
optically scattering medium, and the tubes were then filled with aqueous suspensions of the
nanohexapods or aqueous solutions of ICG at different concentrations. When the solution
was illuminated by laser, PA waves were generated through thermoelastic expansion due to
optical absorption. A 5-MHz central frequency, spherically focused ultrasonic transducer
(V308, Panametrics-NDT, Waltham, MA) was used to collect the PA signals. The signal
was amplified by a low-noise amplifier (5072PR, Panametrics-NDT) and recorded using a
digital oscilloscope (TDS5054, Tektronix, Beaverton, OR). A photodiode (SM05PD1A,
Thorlabs, Newton, NJ) was used to compensate for the energy instability of laser pulses. The
transducer was located inside a water container.
Conjugation of PEG with Au Nanostructures
Typically, 10 mL of ~1.0 nM Au nanohexapods (or nanocages) in ultra-purified H2O was
added to 5.0 mg of mPEG-SH (each Au nanoparticle corresponded to roughly 105 PEG
molecules) and incubated overnight at room temperature. The excess mPEG-SH was
removed by centrifugation at 10,000 rpm for 12 min (10,000 rpm for 10 min for Au
nanocages) and washed three times with ultra-purified H2O to obtain PEGylated Au
nanohexapods (or PEGylated Au nanocages). Conjugation of PEG with CTAB-stabilized Au
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nanorods was carried out using a similar procedure and purified by centrifugation at 8,000
rpm for 15 min. Considering the strong interaction of CTAB with Au nanorods, the
PEGylation was repeated three times for each sample.
Photothermal Study
Aqueous suspensions of Au nanostructures (100 μL, at various particle concentrations) were
placed in a single well of 96-well plate, and irradiated with a diode laser (λ=808 nm) from
the top at a density of 0.8 W/cm2. A NIR camera (ICI7320, Infrared Camera Inc., Beaumont,
TX) was placed on top of the suspension, and thermographs were recorded by the NIR
camera at an interval of five seconds. The thermographs were analyzed using IR Flash
software (Infrared Camera Inc., version 2.10) to obtain the average temperature of the
suspension at each time point.
In Vitro Photothermal Stability
Aqueous suspensions of Au nanostructures (0.1–0.2 nM, 100 μL) were placed in a cap of a
1.5-mL eppendorf centrifuge tube. The suspensions were irradiated with a pulsed laser
(λ=805 nm) from the top at a density ranging from 15–35 mW/cm2 for 15 min, and then the
UV-vis spectra were recorded. A tunable Ti:sapphire laser (730–850 nm, LT-2211A, LOTIS
TII, with pulse width <15 ns and a pulse repetition rate of 10 Hz) pumped by a Q-switched
Nd:YAG (LS- 2137/2, LOTIS TII) was used for irradiation.
Cell Culture
MDA-MB-435 cell line was obtained from the American Type Culture Collection (ATCC,
Manassas, VA). The cells were cultured in MEM medium, supplemented with 5% fetal
bovine serum, penicillin (104 IU)/streptomycin (10 mg/mL), 2 mM L-glutamine, 1 mM
sodium pyruvate, 1 mM non-essential amino acids, and 20 mM vitamins for MEM at 37 °C
using a humidified 5% CO2 incubator.
In Vitro Cell Uptake Studies Using ICP-MS
In the upright configuration, MDA-MB-435 cells were seeded in 24-well plates at a density
of 1 × 105 cells/well and incubated overnight. The cells were washed with PBS and
incubated with the culture medium containing the PEGylated Au nanostructures. After
different intervals of time, the cells were washed three times with cold PBS, treated with 0.2
mL of trypsin solution (containing 0.25% EDTA), and counted with a hematocytometer. The
cell pellets were freeze-dried and 400 μL aqua regia was then added to completely digest the
cells and dissolve the Au nanostructures. The amount of Au was measured by Elan DRC II
ICP-MS (Perkin Elmer, Waltham, MA). Quantification was carried out by external five-
point calibration with internal standard correction. The amount of Au was finally normalized
to the cell number. In the inverted configuration (with the cells facing the bottom of the
well), MDA-MB-435 cells were seeded on round coverslips (diameter = 25 mm, VWR,
Radnor, PA) until ~80% confluence was reached. The coverslips were washed with PBS
five times and suspended from above by gluing a small block of rubber on the back side of
the coverslip and a syringe needle to the inner side of the cover of a 6-well culture plate.35
The cells were incubated with the culture medium containing the PEGylated Au
nanostructures. At different intervals of time, the cells were washed three times with cold
PBS, treated with 0.4 mL of trypsin solution (containing 0.25% EDTA) and counted with a
hematocytometer. The Au content was analyzed using ICP-MS as described above.
In Vitro Cell Growth Inhibition Assay
MDA-MB-435 cells were seeded in 96-well plates at a density of 5 × 103 cells per well in
100 μL of complete MEM medium, and incubated at 37 °C in 5% CO2 humidified
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atmosphere for 24 h. The culture medium was then replaced with 100 μL of freshly prepared
culture medium containing the as-prepared Au nanostructures or the PEGylated Au
nanostructures at different concentrations from 1.56 to 200 μg/mL of Au atoms. The cells
were further incubated for 48 h, and then 25 μL of MTT stock solution (5 mg/mL in PBS)
was added to each well to achieve a final concentration of 1 mg/mL, with the exception of
the well labeled as blank to which 25 μL of PBS was added. After incubation for another 2
h, 100 μL of extraction buffer (20% SDS in 50% DMF, pH 4.7, prepared at 37 °C) was
added to the wells and incubated at 37 °C for another 4 h. The absorbance was measured at
570 nm using an Infinite F200 multimode reader (Tecan, Switzerland). Cell viability was
normalized to that of MDA-MB-435 cells cultured in the complete culture medium.
In Vivo Biodistribution Analysis
Athymic Nude-Foxn1nu nude mice, aged 5–6 weeks, were obtained from Harlan
Laboratories (Indianapolis, IN). The MDA-MB-435 tumor model was generated by
subcutaneous injection of 5 × 106 cells in 30–40 μL PBS into the right rear flanks. Animals
used in biodistribution studies had a tumor volume of 200–300 mm3 for 6 and 24 h studies
and 100–200 mm3 for 7 days experiments. The tumor-bearing mice were randomly divided
into six groups (n = 3 per group). The mice were injected intravenously with 100 μL of
PEGylated Au nanostructures (4 nM). At 6 h, 24 h, and 7 days post injection, animals were
sacrificed and the tissues were taken out, washed, weighed, and then freeze-dried. The tissue
sample was digested with 8 mL of aqua regia in a 20 mL glass vials at boiling temperature.
The solution was evaporated and suspended in aqueous solution containing 0.5% HCl and
1.5% HNO3. The suspension was centrifuged at a speed of 3,000 rpm to remove any
undigested debris prior to ICP-MS measurement. The analysis of Au content was performed
using ICP-MS as described above.
Evaluation of In Vivo Photothermal Conversion Following Intratumoral Injection
Animals were anesthetized with 2% isoflurane (ISoFlo, Abott Laboratories) in 100%
oxygen, placed in a prone position on a table, and injected with 40 μL of an aqueous
suspension of PEGylated Au nanohexapods (1 nM) or saline intratumorally. The entire
region of the tumor was then exposed to a diode laser (808 nm) at a power density of 1.0 W/
cm2. During irradiation, thermographs were taken using a NIR camera as described above.
In Vivo Photothermal Treatment Following Intravenous Injection
MDA-MB-435 tumors were grown in both rear flanks of athymic Nude-Foxn1nu nude mice
in the same way described above (one tumor for irradiation, one for control). Mice were
injected intravenously with 200 μL of PEGylated Au nanostructures or saline (n = 3 per
group, Au atom mass ≈ 0.8 mg per mouse). At 72 h post injection, animals were
anesthetized with 2% isoflurane (ISoFlo, Abott Laboratories) in 100% oxygen and placed in
a prone position on a table. The entire region of the left-side tumor was then exposed to a
diode laser (808 nm) at a power density of 1.2 W/cm2. During irradiation, thermographs
were taken using a NIR camera as described above. 4 days after irradiation, mice were
sacrificed and irradiated sites were interrogated for the presence of tumors.
Positron Emission Tomography/Computed Tomography (PET/CT) Imaging
The photothermal treatment effect on tumor metabolism was assessed by 18F-
flourodeoxyglucose (18F-FDG) PET/CT before the injection of various gold nanostructures
and 24 h post treatment. Athymic nude-foxn1nu nude mice bearing MDA-MB-435 tumors
in each rear flank (one irradiated and one control per mouse) were fasted overnight,
anesthetized with isoflurane (2% in 100% O2), and injected with 3.66 – 4.59 MBq 18F-FDG
in 100 μL saline acquired from the Washington University cyclotron facility via the tail
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vein. A 10 minute static scan was performed one hour after 18F-FDG injection with either an
Inveon microPET/CT Scanner (Siemens, Munich, Germany) or a Focus 220 PET Scanner
(Concorde Microsystems, Knoxville, TN). The microPET images were corrected for
attenuation, scatter, normalization, and camera dead time and co-registered with microCT
images. All of the PET scanners were cross-calibrated periodically. The microPET images
were reconstructed with the maximum a posteriori (MAP) algorithm and analyzed by Inveon
Research Workplace. The tumor uptake of 18F-FDG was calculated in terms of the
standardized uptake value (SUV) in three-dimensional regions of interest (ROIs). In general,
SUV is defined as the tissue concentration of radiotracer divided by the activity injected per
body weight and is calculated according to the following equation:
All the SUV data were not corrected for partial volume effect.41
In Vivo Toxicity
C57BL/6 mice weighing 20–25 g (Charles River Laboratory, Wilmington, MA) were
injected intravenously with 100 μL of PEGylated Au nanostructures or saline (n = 3 per
group, Au atom mass ≈ 0.4 mg per mouse). At 7 days post injection, animals were sacrificed
and the tissues were excised. The excised tissues were embedded in paraffin blocks,
sectioned into 7-mm slices, and stained with hematoxylin and eosin (Sigma–Aldrich) to
assess tissue and cellular morphology.
Instrumentations
The UV-Vis extinction spectra were recorded using a Cary 50 spectrometer (Varian, Palo
Alto, CA). Prior to their use, the Au nanostructures were characterized using a Tecnai G2
Spirit transmission electron microscope (TEM) operated at 120 kV (FEI, Hillsboro, OR).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
UV-vis spectra taken from aqueous suspensions of (A) Au nanohexapods (0.18 nM in
particle concentration or 34.4 μg/mL of Au atoms), (C) Au nanorods (1.4 nM in particle
concentration or 36.4 μg/mL of Au atoms), and (E) Au nanocages (0.024 nM in particle
concentration or 9.6 μg/mL of Au atoms and 3.3 μg/mL of Ag atoms). (B, D, F) TEM
images of the corresponding Au nanostructures. The 50 nm scale bar applies to all images.
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Figure 2.
(A) Plots of temperatures as a function of irradiation time for aqueous suspensions of Au
nanohexapods with different extinction intensities (or particle concentrations) ranging from
0.062 (or 0.011 nM) to 4.0 (or 0.72 nM). The number next to the curve indicates extinction
intensity of the suspension at 805 nm. (B) Plots of temperatures as a function of irradiation
time for suspensions of Au nanohexapods, nanorods, and nanocages. For the purpose of
comparison, the concentration of each suspension was adjusted to give an extinction
intensity of 1.0 at 805 nm. The laser power density was 0.8 W/cm2.
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Figure 3.
(A) Cell viability of MDA-MB-435 cells after incubation with the as-synthesized Au
nanohexapods, nanocages, and nanorods for 48 h. (B) Cell viability of MDA-MB-435 cells
after incubation with the PEGylated Au nanohexapods, nanocages, and nanorods for 48 h.
Error bars are standard errors with n = 6.
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Figure 4.
Uptake of the PEGylated Au nanohexapods, nanocages, and nanorods by MDA-MB-435
cells after incubation for different periods of time. The cells were positioned in (A) upright
configuration and (B) inverted configuration. The initial concentrations of Au atoms in the
culture medium were 10 μg/mL for each sample of Au nanostructures. Error bars are
standard errors with n = 4.
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Figure 5.
In vivo biodistributions of the PEGylated Au nanohexapods, nanocages, and nanorods after
they had been intravenously injected into tumor-bearing mice for (A) 6 h, (B) 24 h, and (C)
7 days. The amounts of Au in the tissues were analyzed by ICP-MS. Error bars are standard
errors with n = 3.
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Figure 6.
A) Thermographs of tumor-bearing mice receiving photothermal treatment for different
periods of time. The mice were intravenously administrated with aqueous suspensions of
PEGylated nanohexapods, nanorods, nanocages, or saline. B) Plots of average temperature
increase within the tumor region as a function of irradiation time. The laser power density
was 1.2 W/cm2. Error bars are standard errors with n = 3.
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Figure 7.
A) 18F-FDG PET/CT co-registered images of mice intravenously administrated with
aqueous suspensions of PEGylated nanohexapods, nanorods, nanocages, or saline. Tumors
were treated either with (solid circle + left arrow) or without (solid circle) laser irradiation.
B) A plot showing 18F-FDG standardized uptake values (SUV) in laser-treated tumor and
non-treated tumor. C) A plot showing the ratios of laser-treated tumor to non-treated
tumor 18F-FDG SUV. Error bars are standard errors with n = 3.
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